For research use only. Not for therapeutic Use.
FX-909（Cat No.:I041367）is a small molecule compound that is primarily studied for its potential therapeutic applications, particularly in cancer research. It is a selective inhibitor of specific enzymes or signaling pathways that contribute to cancer cell growth, survival, and metastasis. FX-909 has been investigated for its ability to block tumor progression by targeting critical molecular pathways involved in cancer development. Ongoing research focuses on its efficacy, safety, and pharmacokinetic properties. FX-909 holds promise as a potential treatment for various types of cancer, offering a novel approach for targeted cancer therapy.
| CAS Number | 2924573-90-8 |
| Synonyms | 3-(5,7-difluoro-4-oxo-1H-quinolin-2-yl)-4-methylsulfonylbenzonitrile |
| Molecular Formula | C17H10F2N2O3S |
| Purity | ≥95% |
| IUPAC Name | 3-(5,7-difluoro-4-oxo-1H-quinolin-2-yl)-4-methylsulfonylbenzonitrile |
| InChI | InChI=1S/C17H10F2N2O3S/c1-25(23,24)16-3-2-9(8-20)4-11(16)13-7-15(22)17-12(19)5-10(18)6-14(17)21-13/h2-7H,1H3,(H,21,22) |
| InChIKey | RBUBBZVQPHSZEZ-UHFFFAOYSA-N |
| SMILES | CS(=O)(=O)C1=C(C=C(C=C1)C#N)C2=CC(=O)C3=C(N2)C=C(C=C3F)F |
